Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine.
作者信息
Leopold Jane A
机构信息
Brigham and Women's Hospital Harvard Medical School Boston, Massachusetts.
出版信息
Am J Respir Cell Mol Biol. 2021 Jan;64(1):12-13. doi: 10.1165/rcmb.2020-0384ED.
Abstract
摘要
相似文献
1
Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine.抑制Jak2可改善肺动脉高压：兑现精准医学的承诺。
Am J Respir Cell Mol Biol. 2021 Jan;64(1):12-13. doi: 10.1165/rcmb.2020-0384ED.
2
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.JAK2 介导特发性肺纤维化中的肺纤维化、肺血管重塑和高血压：一项实验研究。
Thorax. 2018 Jun;73(6):519-529. doi: 10.1136/thoraxjnl-2017-210728. Epub 2018 Feb 10.
3
Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.阻断 JAK2 可通过抑制肺动脉平滑肌细胞增殖来保护小鼠免受低氧诱导的肺动脉高压。
Cell Prolif. 2020 Feb;53(2):e12742. doi: 10.1111/cpr.12742. Epub 2020 Jan 14.
4
The promise of Janus kinase inhibitors in the treatment of hematological malignancies.Janus激酶抑制剂在血液系统恶性肿瘤治疗中的前景。
Cytokine. 2017 Oct;98:33-41. doi: 10.1016/j.cyto.2016.10.012. Epub 2016 Oct 27.
5
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.Janus 激酶-2 与门静脉高压以及啮齿动物和人类肝硬化的并发症直接相关。
Gut. 2017 Jan;66(1):145-155. doi: 10.1136/gutjnl-2015-309600. Epub 2015 Sep 17.
6
Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.费城阴性JAK2阳性骨髓增殖性肿瘤中JAK2等位基因负荷与肺动脉高压及血液学参数的相关性：一项埃及的研究经验
Ann Hematol. 2016 Oct;95(10):1611-6. doi: 10.1007/s00277-016-2765-0. Epub 2016 Jul 29.
7
The Nitric Oxide Pathway-A Potential Target for Precision Medicine in Pulmonary Arterial Hypertension.一氧化氮途径——肺动脉高压精准医学的潜在靶点。
Am J Cardiol. 2017 Oct 15;120(8S):S69-S70. doi: 10.1016/j.amjcard.2017.06.011.
8
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.骨髓增殖性疾病可能是慢性血栓栓塞性肺动脉高压发展的危险因素——一项遗传研究。
Int J Mol Sci. 2020 May 8;21(9):3339. doi: 10.3390/ijms21093339.
9
Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling.JAK2 V617 突变体抑制策略对细胞因子受体信号的差异影响。
J Allergy Clin Immunol. 2019 Jul;144(1):224-235. doi: 10.1016/j.jaci.2018.12.1023. Epub 2019 Jan 29.
10
Panax notoginseng saponins ameliorates experimental hepatic fibrosis and hepatic stellate cell proliferation by inhibiting the Jak2/ Stat3 pathways.三七皂苷通过抑制Jak2/Stat3信号通路改善实验性肝纤维化和肝星状细胞增殖。
J Tradit Chin Med. 2016 Apr;36(2):217-24. doi: 10.1016/s0254-6272(16)30030-9.
引用本文的文献
1
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.肺部综合多组学研究揭示了天冬氨酸聚糖在肺动脉高压中的保护作用。
Circulation. 2024 Oct 15;150(16):1268-1287. doi: 10.1161/CIRCULATIONAHA.124.069864. Epub 2024 Aug 21.
2
Genetic Variants Linked to Myocardial Infarction in Individuals with Non-Alcoholic Fatty Liver Disease and Their Potential Interaction with Dietary Patterns.与非酒精性脂肪性肝病患者心肌梗死相关的遗传变异及其与饮食模式的潜在相互作用。
Nutrients. 2024 Feb 22;16(5):602. doi: 10.3390/nu16050602.
3
Pulmonary Hypertension: A Contemporary Review.肺动脉高压：当代综述。
Am J Respir Crit Care Med. 2023 Sep 1;208(5):528-548. doi: 10.1164/rccm.202302-0327SO.
4
Inhibition of JAK1,2 Prevents Fibrotic Remodeling of Pulmonary Vascular Bed and Improves Outcomes in the Rat Model of Chronic Thromboembolic Pulmonary Hypertension.抑制 JAK1、2 可预防肺血管床的纤维化重塑，并改善慢性血栓栓塞性肺动脉高压大鼠模型的结局。
Int J Mol Sci. 2022 Dec 9;23(24):15646. doi: 10.3390/ijms232415646.
5
Clonal hematopoiesis of indeterminate potential and cardiovascular disease.意义未明的克隆性造血与心血管疾病
Transl Res. 2023 May;255:152-158. doi: 10.1016/j.trsl.2022.08.013. Epub 2022 Sep 5.
6
Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat.去甲辛弗林减轻大鼠野百合碱诱导的肺动脉高压
Front Cardiovasc Med. 2022 Jun 3;9:859422. doi: 10.3389/fcvm.2022.859422. eCollection 2022.
7
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway.多酚类植物化学物质对JAK-STAT信号通路的药理作用。
Front Pharmacol. 2021 Sep 3;12:716672. doi: 10.3389/fphar.2021.716672. eCollection 2021.
8
Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.基于新冠肺炎合并症通路串扰预测靶点和药物：迈向个性化新冠肺炎管理
Biomedicines. 2021 May 17;9(5):556. doi: 10.3390/biomedicines9050556.
本文引用的文献
1
Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension.靶向 Jak-Stat 信号通路治疗实验性肺动脉高压
Am J Respir Cell Mol Biol. 2021 Jan;64(1):100-114. doi: 10.1165/rcmb.2019-0431OC.
2
Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.阻断 JAK2 可通过抑制肺动脉平滑肌细胞增殖来保护小鼠免受低氧诱导的肺动脉高压。
Cell Prolif. 2020 Feb;53(2):e12742. doi: 10.1111/cpr.12742. Epub 2020 Jan 14.
3
-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure.介导的克隆性造血加速小鼠心力衰竭中的病理重塑。
JACC Basic Transl Sci. 2019 Sep 18;4(6):684-697. doi: 10.1016/j.jacbts.2019.05.013. eCollection 2019 Oct.
4
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again.药物重新定位用于治疗肺动脉高压：旧药新用
J Am Heart Assoc. 2019 Jan 8;8(1):e011343. doi: 10.1161/JAHA.118.011343.
5
Drug repurposing: progress, challenges and recommendations.药物重定位：进展、挑战和建议。
Nat Rev Drug Discov. 2019 Jan;18(1):41-58. doi: 10.1038/nrd.2018.168. Epub 2018 Oct 12.
6
Emerging Role of Precision Medicine in Cardiovascular Disease.精准医学在心血管疾病中的新兴作用。
Circ Res. 2018 Apr 27;122(9):1302-1315. doi: 10.1161/CIRCRESAHA.117.310782.
7
Emerging therapeutics in pulmonary hypertension.肺动脉高压的新兴治疗方法。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L769-L781. doi: 10.1152/ajplung.00259.2017. Epub 2018 Feb 1.
8
Precision medicine in cardiology.心脏病学中的精准医学。
Nat Rev Cardiol. 2016 Oct;13(10):591-602. doi: 10.1038/nrcardio.2016.101. Epub 2016 Jun 30.
9
Myocardial Hypertrophic Remodeling and Impaired Left Ventricular Function in Mice with a Cardiac-Specific Deletion of Janus Kinase 2.心脏特异性缺失Janus激酶2的小鼠的心肌肥厚性重塑和左心室功能受损
Am J Pathol. 2015 Dec;185(12):3202-10. doi: 10.1016/j.ajpath.2015.08.007.
10
Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts.心脏蛋白激酶：心肌细胞激酶组和人类衰竭心脏中的差异激酶表达。
Cardiovasc Res. 2015 Oct 1;108(1):87-98. doi: 10.1093/cvr/cvv210. Epub 2015 Aug 10.
Zotero 插件